Ruoyu Ling

474 total citations
9 papers, 332 citations indexed

About

Ruoyu Ling is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ruoyu Ling has authored 9 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Ruoyu Ling's work include RNA modifications and cancer (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Epigenetics and DNA Methylation (2 papers). Ruoyu Ling is often cited by papers focused on RNA modifications and cancer (3 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Epigenetics and DNA Methylation (2 papers). Ruoyu Ling collaborates with scholars based in China and United States. Ruoyu Ling's co-authors include Guoxin Li, Daoming Zhu, Hao Chen, Xianwen Wang, Haisheng Qian, Konglin Wu, Meng Lyu, Jiayong He, Gengtai Ye and Qingbin Yang and has published in prestigious journals such as Advanced Science, Theranostics and Nano Research.

In The Last Decade

Ruoyu Ling

9 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruoyu Ling China 6 182 85 82 73 72 9 332
Kezhou Xia China 12 181 1.0× 96 1.1× 88 1.1× 52 0.7× 51 0.7× 23 350
Sung Ouk Nam Japan 10 130 0.7× 96 1.1× 79 1.0× 42 0.6× 82 1.1× 15 315
Chengwu Zhang China 12 245 1.3× 143 1.7× 94 1.1× 82 1.1× 59 0.8× 28 459
Dechun Liu China 10 139 0.8× 118 1.4× 108 1.3× 56 0.8× 74 1.0× 16 364
Yanyan Jiang China 10 127 0.7× 72 0.8× 98 1.2× 75 1.0× 44 0.6× 17 314
Shoujie Zhao China 10 202 1.1× 118 1.4× 76 0.9× 137 1.9× 56 0.8× 27 502
Yanrui Liang China 5 139 0.8× 65 0.8× 57 0.7× 28 0.4× 83 1.2× 9 273
Xiteng Yin China 10 168 0.9× 77 0.9× 157 1.9× 79 1.1× 72 1.0× 16 374

Countries citing papers authored by Ruoyu Ling

Since Specialization
Citations

This map shows the geographic impact of Ruoyu Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruoyu Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruoyu Ling more than expected).

Fields of papers citing papers by Ruoyu Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruoyu Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruoyu Ling. The network helps show where Ruoyu Ling may publish in the future.

Co-authorship network of co-authors of Ruoyu Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Ruoyu Ling. A scholar is included among the top collaborators of Ruoyu Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruoyu Ling. Ruoyu Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lei, Xuetao, Yanmei Peng, Guofan Zhang, et al.. (2025). Targeting the NAT10/XIST/YAP1 Axis-Mediated Vascular Abnormalization Enhances Immune Checkpoint Blockade in Gastric Cancer. International Journal of Biological Sciences. 21(11). 4997–5014. 1 indexed citations
2.
Yu, Yan, Qichen Chen, Jiayong He, et al.. (2025). UBAP2L-driven stress granule formation links oxaliplatin resistance to gastric cancer. Communications Biology. 8(1). 1208–1208. 1 indexed citations
3.
Chen, Hao, et al.. (2025). CD44v6-mediated regulation of gastric cancer stem cells: a potential therapeutic target. Clinical and Experimental Medicine. 25(1). 80–80. 4 indexed citations
4.
Peng, Yanmei, Xuetao Lei, Qingbin Yang, et al.. (2024). Helicobacter pylori CagA-mediated ether lipid biosynthesis promotes ferroptosis susceptibility in gastric cancer. Experimental & Molecular Medicine. 56(2). 441–452. 18 indexed citations
5.
Yang, Qingbin, Xuetao Lei, Jiayong He, et al.. (2023). N4‐Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF‐1α Positive Feedback Loop. Advanced Science. 10(23). e2300898–e2300898. 55 indexed citations
6.
Yang, Qingbin, Xuetao Lei, Jiayong He, et al.. (2023). N4‐Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF‐1α Positive Feedback Loop (Adv. Sci. 23/2023). Advanced Science. 10(23). 7 indexed citations
7.
Wang, Hao, Jing Wu, Ruoyu Ling, et al.. (2022). Fibroblast-derived LPP as a biomarker for treatment response and therapeutic target in gastric cancer. Molecular Therapy — Oncolytics. 24. 547–560. 11 indexed citations
8.
Zhu, Daoming, Ruoyu Ling, Hao Chen, et al.. (2022). Biomimetic copper single-atom nanozyme system for self-enhanced nanocatalytic tumor therapy. Nano Research. 15(8). 7320–7328. 107 indexed citations
9.
Ye, Gengtai, Qingbin Yang, Xuetao Lei, et al.. (2020). Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis. Theranostics. 10(17). 7545–7560. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026